Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03831555 · ClinicalTrials.gov registry record · NA
Tool to Improve Treatment Adherence and Outcomes at Grady Liver Clinic
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT03831555: Completed NA study, sponsored by Emory University.
NCT03831555 is a NA study that has completed, run by Emory University. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03831555, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about what psychological and social factors affect people in how they take their hepatitis C medications.
Primary Outcome
Adherence to HCV treatment will be measured by documenting the number of participants keeping their follow-up appointments. This data will be collected from chart reviews.
Interventions
- BEHAVIORAL PREP-C
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-06-05 |
| Est. Completion | 2018-06-30 |
| Phase | NA |
What the finished NCT03831555 record still lists
NCT03831555 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which PREP-C is the first listed.
NCT03831555 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03831555 about?
NCT03831555 is a clinical study titled "Tool to Improve Treatment Adherence and Outcomes at Grady Liver Clinic". The purpose of this study is to learn more about what psychological and social factors affect people in how they take their hepatitis C medications.
What is the current status of trial NCT03831555?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2017-06-05. Estimated completion is 2018-06-30.
What interventions are being tested in trial NCT03831555?
The interventions under investigation include: PREP-C (BEHAVIORAL).
Who is sponsoring clinical trial NCT03831555?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03831555's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI